Compare Earth Corp. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with a -1.82% CAGR growth in Net Sales over the last 5 years
2
Poor long term growth as Net Sales has grown by an annual rate of -1.82% over the last 5 years
3
Negative results in Mar 26
4
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
JPY 103,276 Million (Small Cap)
16.00
NA
0.00%
0.06
8.19%
1.35
Revenue and Profits:
Net Sales:
47,914 Million
(Quarterly Results - Mar 2026)
Net Profit:
4,512 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
2.05%
0%
2.05%
6 Months
-4.83%
0%
-4.83%
1 Year
-6.44%
0%
-6.44%
2 Years
0.32%
0%
0.32%
3 Years
-6.44%
0%
-6.44%
4 Years
-9.48%
0%
-9.48%
5 Years
-29.48%
0%
-29.48%
Earth Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-1.82%
EBIT Growth (5y)
-10.63%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0.13
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
2.12
Tax Ratio
31.79%
Dividend Payout Ratio
50.00%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.05%
ROE (avg)
10.16%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
1.34
EV to EBIT
13.09
EV to EBITDA
8.20
EV to Capital Employed
1.32
EV to Sales
0.59
PEG Ratio
5.18
Dividend Yield
NA
ROCE (Latest)
10.10%
ROE (Latest)
8.19%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
47,914.00
44,782.00
6.99%
Operating Profit (PBDIT) excl Other Income
7,568.00
7,390.00
2.41%
Interest
42.00
26.00
61.54%
Exceptional Items
0.00
309.00
-100.00%
Consolidate Net Profit
4,512.00
4,735.00
-4.71%
Operating Profit Margin (Excl OI)
132.30%
140.00%
-0.77%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is 6.99% vs 6.50% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is -4.71% vs 31.35% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
179,182.00
169,278.00
5.85%
Operating Profit (PBDIT) excl Other Income
12,800.00
10,996.00
16.41%
Interest
90.00
38.00
136.84%
Exceptional Items
-625.00
-1,374.00
54.51%
Consolidate Net Profit
5,591.00
3,792.00
47.44%
Operating Profit Margin (Excl OI)
44.90%
38.00%
0.69%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 5.85% vs 6.91% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 47.44% vs -14.01% in Dec 2024
About Earth Corp. 
Earth Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






